Compare ALLO & CLMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ALLO | CLMB |
|---|---|---|
| Founded | 2017 | 1982 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Retail: Computer Software & Peripheral Equipment |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 539.4M | 436.8M |
| IPO Year | 2018 | 1996 |
| Metric | ALLO | CLMB |
|---|---|---|
| Price | $2.32 | $21.16 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 15 | 2 |
| Target Price | $8.35 | ★ $80.00 |
| AVG Volume (30 Days) | ★ 14.4M | 121.6K |
| Earning Date | 05-12-2026 | 04-29-2026 |
| Dividend Yield | N/A | ★ 0.60% |
| EPS Growth | ★ 34.09 | 14.29 |
| EPS | N/A | ★ 4.64 |
| Revenue | N/A | ★ $652,517,000.00 |
| Revenue This Year | N/A | $7.82 |
| Revenue Next Year | $142,416.42 | $5.83 |
| P/E Ratio | ★ N/A | $4.57 |
| Revenue Growth | N/A | ★ 40.14 |
| 52 Week Low | $0.86 | $19.16 |
| 52 Week High | $4.46 | $145.00 |
| Indicator | ALLO | CLMB |
|---|---|---|
| Relative Strength Index (RSI) | 47.27 | 15.74 |
| Support Level | $1.92 | $19.16 |
| Resistance Level | $2.71 | $23.60 |
| Average True Range (ATR) | 0.35 | 0.95 |
| MACD | -0.04 | 2.75 |
| Stochastic Oscillator | 17.82 | 13.80 |
Allogene Therapeutics Inc is a clinical-stage biotech firm specializing in immuno-oncology, focusing on the development of genetically engineered allogeneic T-cell products for cancer and autoimmune diseases. Their pipeline includes off-the-shelf T-cell candidates designed to target cancer cells or autoreactive cells in autoimmune disorders. Notably, their allogeneic approach, derived from healthy donors, allows for broader patient eligibility and scalability. With a vision to redefine CAR T therapy, the company concentrates on core programs targeting lymphoma, leukemia, autoimmune diseases, and solid tumors. Revenue, generated from collaborations and licensing agreements, supports their research and development efforts.
Climb Global Solutions Inc is a cloud-based, value-added IT distribution and solutions company specializing in emerging technologies. It operates across the USA, Canada, and Europe through multiple business units, including Climb Channel Solutions, Sigma, Grey Matter, Interwork, and TechXtend. The company is organized into two reportable operating segments. The Distribution segment distributes technical software to corporate resellers, value-added resellers (VARs), consultants, and systems integrators under the name Climb Channel Solutions. The Solutions segment is a cloud solutions provider and value-added reseller of software, hardware, and services to customers under the name Grey Matter.